The Lancet Haematology· Hanny Al-Samkari, Fouzia Aboobacker, Biree Andemariam, Perla Eleftheriou, Hatoon Ezzat, Dimitrios Farmakis, Shahrukh Hashmi, Shruti Kakkar, Aurelio Maggio, Antonio Piga, Alok Srivastava, Mohamed A Yassin, Hasan Abbas Zaheer, Vip Viprakasit, Khaled M Musallam·· 2026-10-07AI 评分31
未来保障地中海贫血治疗:规模化疗法、人工智能与全球合作
[Series] Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration
AI 导读
过去30年,地中海贫血治疗取得重大进展,生存率和生活质量显著提高,得益于干细胞移植、输血安全、铁过载监测和螯合疗法的进步。然而,低收入和中等收入国家仍存在显著的专科治疗和新型疗法可及性差异。
来源:The Lancet Haematology · thelancet.com